Catheter Precision (VTAK) Free Cash Flow Growth (3y) (2020 - 2026)
Catheter Precision (VTAK) Free Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 9.23% |
| 10 | Catheter Precision | 564,834.50 | -1.27 Mn | 98,000.00 | 15.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.62% |
| Dec 31, 2025 | 20.72% |
| Sep 30, 2025 | 23.95% |
| Jun 30, 2025 | 27.69% |
| Mar 31, 2025 | 35.08% |
| Dec 31, 2024 | 20.51% |
| Sep 30, 2024 | 27.06% |
| Jun 30, 2024 | 35.94% |
| Mar 31, 2024 | 37.87% |
| Dec 31, 2023 | 41.26% |
| Sep 30, 2023 | 32.93% |
| Jun 30, 2023 | 5.79% |
| Mar 31, 2023 | -19.58% |
| Dec 31, 2022 | 31.87% |
| Sep 30, 2022 | 14.33% |
| Jun 30, 2022 | 4.10% |
| Mar 31, 2022 | 2.02% |
| Dec 31, 2021 | 12.66% |
| Sep 30, 2021 | -18.23% |
| Jun 30, 2021 | -22.26% |